Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.

Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.

An early-stage, blood-based assay shows potential as a method for sorting patients with suspected TB from those with other respiratory illnesses.

The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.

Tweaking the genomes of two phages and combining them with a third phage helped to clear a persistent Mycobacterium infection in the patient.

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

The information we’ve gathered showed us that warthogs can be used as disease sentinels, avoiding the need to resort to testing valuable or endangered animals.

A new facility located in a congested community with high tuberculosis rates brings basic science and cutting edge techniques into the heart of disease circulation.

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.